NPPA and depressive symptom measurement: Accumulating evidence suggests that KP imbalance, which is characterized by an abnormal ratio of neurotoxic to neuroprotective metabolites in kynurenines, has been associated with the development of depression (Brown et al., 2021; Deng et al., 2021; Ou et al., 2023).